Develop a new drug for someone Who might be suffering somewhere in the world.
DESIGNING DRUG COMBINATION
FOR ORPHAN DISEASE PATIENTS
Smarter,Faster,Safer
Simply a better way for drug development
THE MULTI-PRONGED APPROACH

Let's open up new markets and revenue streams by predicting more than one promising indication for a drug candidate at the early development stage.

We are a specialized discovery team with novel technologies and unique massive bio-pharmacological data resources for discovering hidden possibilities of drugs.

DRUG COMBINATION

Two major causes of failure in clinical trials are lack of safety (~45% failure rate in Phase I) and efficacy (~65% failure rate in Phase II).
A synergistic drug combination increases the efficacy of the therapeutic effect and reduces toxicity as a result of decreased dosage.

Using our unique Multi-Strategy Drug Repositioning System, we will find the most synergistic drug partner that will target multiple pathological networks with your drug.

ORPHAN DISEASE

In the process of researching for orphan diseases, one may come across the problem of a lack of information.

That's where we step in. We can predict the pathological networks and suggest suitable drugs for diseases, on which you may have limited knowledge.

"NOAH's NOTE"
OUR DATABASES
"NOAH's ARK"
MULTI-STRATEGY DRUG DESIGNING SYSTEM
CONTACT
지도 크게 보기
2017.3.13  |  지도 크게 보기 ©   NAVER Corp.
Tel. +82-31-8014-5968

Fax. +83-31-8014-5969

Email. contact@drnoahbiotech.com

Addr.
(16226) 경기도 수원시 영통구 대학4로 17 에이스광교 지식산업센터 1004-1호
(16226) ACE Gwanggyo Tower 1004-1Ho, 17, Daehak 4-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea

DR.NOAH BIOTECH on Facebook

TOP